Ganciclovir for Injection is administered intravenously, and its dosage needs to be determined according to the stage of treatment, the patient’s weight in kilograms, etc., ranging from 0.625mg/Kg to 5mg/Kg, and needs to be titrated by a doctor.
Ganciclovir for injection is a reverse transcriptase inhibitor, and its main ingredient is ganciclovir, which is mainly used for the treatment of cytomegalovirus retinitis in immunodeficient persons and the prophylaxis of a series of cytomegalovirus diseases in patients who have received organ transplants and have the possibility of cytomegalovirus infection.
When administered intravenously, it is usually diluted in a solution of compounded sodium chloride, sodium chloride, or 5% dextrose as prescribed by the physician before being administered intravenously.
Treatment with ganciclovir for injection is divided into two main phases: the induction phase and the maintenance phase. The dosage in the induction phase varies between 1.25mg/Kg/12h to 5mg/Kg/12h. The dosage in the maintenance phase varies between 0.625mg/Kg/24h~5mg/Kg/24h. The specific dosage and frequency of medication need to be based on the doctor’s instructions, and should not be changed privately.
During the use of the drug, patients may experience myelosuppression, tremor and other adverse reactions. People who are allergic to acyclovir and ganciclovir need to disable this product.